Mitessh Thakkar: BUY Oracle Financial, SUN TV; SELL Bharti Airtel and Can Fin Homes

Neeta Aurora 3 November 2022
Mitessh Thakkar: BUY Oracle Financial, SUN TV; SELL Bharti Airtel and Can Fin Homes

Market analyst Mitesh Thakkar has suggested two BUY Calls and two SELL Calls for today’s trading session. Indian markets are expected to open flat today and we could see selling at higher levels.

Ashish Chaturvedi: BUY Schneider Electric, Grindwell Norton, ONGC; SELL LIC Housing

Keshav Seth 2 November 2022
Ashish Chaturvedi: BUY Schneider Electric, Grindwell Norton, ONGC; SELL LIC Housing

Market expert Ashish Chaturvedi has suggested three BUY Calls and one SELL Call for today’s trading session.

Sudarshan Sukhani: BUY Hindalco, Dr Reddy’s, Lupin; SELL LIC Housing

Divesh Sharma 2 November 2022
Sudarshan Sukhani: BUY Hindalco, Dr Reddy’s, Lupin; SELL LIC Housing

Technical Analyst Sudarshan Sukhani has suggested three BUY Calls and one SELL Call for today’s trading session.

Mitessh Thakkar: BUY Asian Paints, Aurobindo Pharma, Mindtree; SELL IDFC

Neeta Aurora 2 November 2022
Mitessh Thakkar: BUY Asian Paints, Aurobindo Pharma, Mindtree; SELL IDFC

Market analyst Mitesh Thakkar has suggested three BUY Calls and one SELL Call for today’s trading session.

Kushal Gupta: BUY Hindalco, Tata Motors, Kansai Nerolac and Eicher Motors

Sukant Sharma 2 November 2022
Kushal Gupta: BUY Hindalco, Tata Motors, Kansai Nerolac and Eicher Motors

Market expert Kushal Gupta has suggested four BUY Calls and no SELL Call for today’s trading session.

Two Standouts Outperform During Global Debt Route

Gaurav Mehra 2 November 2022
Two Standouts Outperform During Global Debt Route

India and Indonesia's debt outperformed during the recent extreme volatility in the global capital markets.

Pages

News in Focus

Hindalco Industries Share Price Target at Rs 735: Kotak Institutional Equities
Hindalco Industries Share Price Target at Rs 735: Kotak Institutional Equities
Featured, Analyst View, Hindalco, India, Kotak Securities, Metals Sector

Hindalco Industries continues to demonstrate strategic resilience and operational superiority across its core verticals.

Interglobe Aviation (Indigo) Share Price Target at Rs 6,377: ICICI Securities
Interglobe Aviation (Indigo) Share Price Target at Rs 6,377: ICICI Securities
Featured, Analyst View, Aviation Sector, ICICI Securities, India, Indigo Airlines

IndiGo’s Q4 FY25 results have reinforced investor optimism, prompting ICICI Securities to maintain its BUY call on InterGlobe Aviation with an upgraded target price of Rs. 6,377 (previously Rs.

Power Grid Corporation Share Price Target at Rs 361: ICICI Securities
Power Grid Corporation Share Price Target at Rs 361: ICICI Securities
Featured, India Business, Analyst View, ICICI Securities, Power Grid, Power Sector

Power Grid Corporation of India (PGCIL) has drawn a fresh vote of confidence from ICICI Securities, which has maintained its BUY rating with a 12-month target price of Rs 361, implying a potential

ITC Share Price Could Reach Rs 538: Prabhudas Lilladher Research
ITC Share Price Could Reach Rs 538: Prabhudas Lilladher Research
Featured, Analyst View, Stock Markets, FMCG Sector, India, ITC, Prabhudas Lilladher

ITC Ltd has received an upgrade from Prabhudas Lilladher, with the research house elevating its rating to BUY and revising the target price to Rs 538 from the previous Rs 524.

IndusInd Bank Share Price Target at Rs 737: LKP Research Downgrades Stock
IndusInd Bank Share Price Target at Rs 737: LKP Research Downgrades Stock
Featured, Analyst View, Banking Sector, India, Indusind Bank, LKP Securities

IndusInd Bank has encountered one of its most turbulent quarters in recent memory, and LKP Research has acted swiftly in response, slashing its rating to REDUCE and assigning a revised 12-month tar

Sun Pharmaceutical Share Price Target at Rs 2,000: Motilal Oswal Research
Sun Pharmaceutical Share Price Target at Rs 2,000: Motilal Oswal Research
Featured, Analyst View, India, Motilal Oswal, Pharmaceutical Sector, Sun Pharmaceutical

Motilal Oswal has reiterated a BUY recommendation on Sun Pharma, assigning a target price of Rs 2,000, implying a 16% upside from its current market price of Rs 1,719.